Physician profile
Kermit A Murray
NPI 1700896719
$1,465.80
in general payments reported to CMS, 2019-2025
15 companies · $20.71 in 2025
The $20.71 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $228 · 2021: $255 · 2022: $16.29 · 2023: $221 · 2024: $66.33 · 2025: $20.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $406.57 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $226.10 | 2019-2024 | Breztri, Airsupra |
| Lilly USA, LLC | $174.06 | 2019-2024 | Mounjaro, Zepbound |
| Medtronic, INC. | $132.00 | 2023 | Interstim |
| Boston Scientific Corporation | $124.98 | 2021 | |
| Amarin Pharma, INC. | $105.01 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $84.45 | 2019-2020 | |
| Glaxosmithkline, LLC. | $62.71 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Sanofi Pasteur INC. | $37.89 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.89 | 2020 | |
| Pfizer INC. | $22.38 | 2023 | |
| Cranial Technologies, INC | $20.41 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.73 | 2019 | |
| Allergan, INC. | $12.29 | 2020 | |
| Merck Sharp & Dohme LLC | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kermit Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.